Growth factor modulation of hepatic inflammation: a novel approach to the management of total parenteral nutrition-associated liver disease

Journal of Pediatric Surgery

Volumn 45, Issue 1, 2010, Pages 89-94

  Thatch, Keith A ^a   Katz, Michael S ^a   Haber, Marian M ^b   Schwartz, Marshall Z ^a,b  

^a ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Naphtylisocyocyanate; Chronic liver injury; Hepatic apoptosis; Hepatocyte growth factor; Liver inflammation; TPN induced liver injury

Indexed keywords

INTERLEUKIN 6; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHOLESTASIS; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATIC DUCT; HEPATITIS; LIVER BIOPSY; LIVER DISEASE; LIVER INJURY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; TOTAL PARENTERAL NUTRITION;

1-NAPHTHYLISOTHIOCYANATE; ANIMALS; CHOLESTASIS, INTRAHEPATIC; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; FEMALE; HEPATOCYTE GROWTH FACTOR; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INTERLEUKIN-6; LIVER; LIVER DISEASES; LIVER FAILURE; LIVER FUNCTION TESTS; PARENTERAL NUTRITION, TOTAL; RATS; RATS, SPRAGUE-DAWLEY; SHORT BOWEL SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 72649085709     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2009.10.016     Document Type: Article

References (33)

1. Diamond I.R., deSilva N., Pencharz P.B., et al. Neonatal short bowel syndrome outcomes after the establishment of the first Canadian multidisciplinary intestinal rehabilitation program: preliminary experience. J Pediatr Surg 42 5 (2007) 806-811
2. DeLegge M., Alsolaiman M.M., Barbour E., et al. Short bowel syndrome: parenteral nutrition versus intestinal transplantation. Where are we today. Dig Dis Sci 52 4 (2007) 876-892
3. Dudrick S., Wilmore D., Vars H., et al. Can intravenous feeding as the sole means of nutritional support growth in the child and restore weight loss in an adult? An affirmative answer. Ann Surg 6 (1969) 974-984
4. Wilmore D.W., Dudrick S.J., Daly J.M., et al. The role of nutrition in the adaptation of the small intestine after massive resection. Surg Gynecol Obstet 132 4 (1971) 673-680
5. Wilmore D.W., and Dudrick S.J. Growth and development of an infant receiving all nutrients exclusively by vein. JAMA 203 10 (1968) 860-864
6. Postuma R., and Trevenue C.L. Liver disease in infants receiving total parenteral nutrition. Pediatrics 63 (1979) 110-115
7. Vanderhoof J.A., and Langnas A.N. Short-bowel syndrome in children and adults. Gastroenterology 113 5 (1997) 1767-1778
8. Thatch K.A., Schwartz M.Z., Yoo E.Y., et al. Modulation of the inflammatory response and apoptosis using epidermal growth factor and hepatocyte growth factor in a liver injury model: a potential approach to the management and treatment of cholestatic liver disease. J Pediatr Surg 43 12 (2008) 2169-2173
9. Meehan J.J., and Georgeson K.E. Prevention of liver failure in parenteral nutrition-dependent children with short bowel syndrome. J Pediatr Surg 32 (1997) 473-475
10. Schwartz M.Z., Kato Y., Yu D., et al. Growth-factor enhancement of compromised gut function following massive small-bowel resection. Pediatr Surg Int 16 (2000) 184-195
11. Kato Y., Yu D., Lukish J.R., et al. Hepatocyte growth factor enhances intestinal mucosal cell function and mass in vivo. J Pediatr Surg 32 (1997) 991-994
12. Schaffner F., Scharnbeck H.H., Hutterer F., et al. Mechanism of cholestasis. VII. α-Naphtylisocyocyanate-induced jaundice. Lab Invest 28 (1973) 321-331
13. Goldfarb S., Singer E.J., and Popper H. Experimental cholangitis due to alpha-naphthylisothiocyanate (ANIT). Am J Pathol 40 (1962) 685-698
14. Tjandra K., Sharkey K.A., and Swain M.G. Progressive development of aTh1-type hepatic cytokine profile in rats with experimental cholangitis. Hepatology 31 (2000) 280-290
15. Li Z., Yang S., Lin H., et al. Probiotics and Antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37 (2003) 343-350
16. Streit W.J., Hurley S.D., McGraw T.S., et al. Comparative evaluation of cytokine profiles and reactive gliosis supports a critical role for interleukin-6 in neuron-glia signaling during regeneration. J Neurosci Res 61 (2000) 10-20
17. Vassilakopoulos T., Heinrich P.C., Muller-Newen G., et al. Differential cytokine gene expression in the diaphragm in response to strenuous resistive breathing. Am J Respir Crit Care Med 170 (2004) 154-161
18. Georgieva G.S., Kurata S., Ikeda S., et al. Prevention of ischemia reperfusion injury by positive pulmonary venous pressure in isolated rat lung. Shock 25 (2006) 66-72
19. Messing B., Crenn P., Beau P., et al. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 117 (1999) 1043-1050
20. Teitelbaum D.H., and Tracy T. Parenteral nutrition-associated cholestasis. Semin Pediatr Surg 10 (2001) 72
21. Roy C.C., and Belli D.C. Hepatobiliary complications associated with TPN: an enigma. J Am Coll Nutr 4 6 (1985) 651-660
22. Li S., Nussbaum M.S., Teague D., et al. Increasing dextrose concentrations in total parenteral nutrition (TPN) causes alterations in hepatic morphology and plasma levels of insulin and glucagon in rats. J Surg Res 44 (1988) 639-648
23. Fisher R.L. Hepatobiliary abnormalities associated with total parenteral nutrition. Gastroenterol Clin North Am 18 3 (1989) 645-666
24. Beath S.V., Davies P., Papadopoulou A., et al. Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg 31 (1996) 604-606
25. Modi B.P., Langer M., Ching Y.A., et al. Improved survival in a multidisciplinary short bowel syndrome program. J Pediatr Surg 43 1 (2008) 20-24
26. Hyde M.J., Amusquivar E., Laws J., et al. Effects of lipid-supplemented total parenteral nutrition on fatty liver disease in a premature neonatal piglet model. Neonatology 93 2 (2007) 77-86
27. Teitelbaum J.E., and Walker W.A. Review: the role of omega 3 fatty acids in intestinal inflammation. J Nutr Biochem 12 (2001) 21-32
28. Wanten G.J., and Calder P.C. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr 85 5 (2007) 1171-1184
29. Alwayn I.P., Andersson C., Zauscher B., et al. Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor. Transplantation 79 5 (2005) 606-608
30. Lee S., Gura K.M., and Puder M. Omega-3 fatty acids and liver disease. Hepatology 45 4 (2007) 841-845
31. Lee S., Kim S., Le H.D., et al. Reduction of hepatocellular injury after common bile duct ligation using omega-3 fatty acids. J Pediatr Surg 43 11 (2008) 2010-2015
32. Gura K.M., Duggan C.P., Collier S.B., et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 118 1 (2006) e197-e201
33. Yoshikawa A., Kaido T., Seto S., et al. Hepatocyte Growth factor promotes liver regeneration with prompt improvement of hyperbilirubinemia in hepatectomized cholestatic liver. J Surg Res 78 (1998) 54-59